Skip to content

Integrated Homoeopathy and WHO rehabilitation care for long COVID

A prospective interventional study to assess role of an integrated approach of Homoeopathy along with WHO Rehabilitation self-management care for long COVID: Single blind placebo controlled randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050878
Enrollment
80
Registered
2023-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

Intervention1: Indicated homoeopathic medicines and WHO Rehabilitation Self-Management after COVID-19 : Homoeopathic drugs as detailed in the standard Homoeopathic Materia Medica and in the Homoeopath

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: History of confirmed COVID-19 infection in last 6 months; Minimum 4 weeks after the confirmed COVID-19 report. Residual or any other clinical complaints reported to be occurring after COVID-19 like fatigue, fever (unknown reason), anxiety, joint pain, breathlessness, headache, or any other non-serious clinical illness not explained by an alternative diagnosis. Cases who have recovered clinically&/or laboratory confirmed negative. Patients agreeing to perform WHO self-care rehabilitation program under guidance of the physician. Patients willing to participate in the study and give written informed consent

Exclusion criteria

Exclusion criteria: Patients having any serious sequelae, presence of systemic complications (persistent organic damage) or specific organ dysfunction due to SARS-CoV-2 virus. Uncontrolled cases of DM, HT, Asthma, HIV, active TB, Cancer, immune compromised illness like HIV etc. Patients having severe dyspnoea with Oxygen saturation below 95%; patients requiring ventilation support Patient reporting having Psychiatric disorders, hepatic and renal dysfunction. Contra indications to physical exercise or Patient unable to do exercise in the WHO rehabilitation self-management care plan. Patients not able to give written informed consent

Design outcomes

Primary

MeasureTime frame
Change in symptom severity or clinical recovery of Long COVID complaintsTimepoint: At baseline, monthly follow-up up to 6 months

Secondary

MeasureTime frame
Change in functional status assessed using PCFS. 6-minute walk test (the distance acquired during six minutes walking) quantifying the physical performance, any dyspnoea and endurance. Changes in fatigue: Chalder Fatigue Scale (CFQ-11) scale Changes in anxiety: Hamilton Anxiety Rating Scale (HAM-A) Changes in health-related quality of life: 12-item Short Form Survey (SF12) Change in numeric rating scale (NRS) for all other complaints Timepoint: At baseline, and up to 6 months

Countries

India

Contacts

Public ContactDr Deepti Singh

Central Council for Research in Homoeopathy

dr.deepti.2821@gmail.com9818785593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026